ConductScience.org, home

Paper338281

Interindividual differences in the response to oral anticoagulants.

Breckenridge AM. Drugs, 1977. Cited by 42 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Interindividual differences in the response to oral anticoagulants. Papers, record 338281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/338281

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interindividual differences in the response to oral anticoagulants.
PubMed
Journal
Drugs
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Breckenridge AMA M

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
Administration, Oral
Biological Availability
Coumarins
Humans
Kinetics
Liver Diseases
Malabsorption Syndromes
Pharmaceutical Preparations
Receptors, Drug
Vitamin K

Source PubMed

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,918,964Determinants of the response to oral anticoagulant drugs in man.Pharmacol Rev1970https://conductscience.org/library/papers/4918964PubMed
2797,504Drug interactions and clinical pharmacokinetics.Clin Pharmacokinet1976https://conductscience.org/library/papers/797504PubMed
34,830,012Letter: Effect of plasma protein binding on elimination of warfarin.J Pharm Sci1974https://conductscience.org/library/papers/4830012PubMed
452,353The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.Aust N Z J Med1975https://conductscience.org/library/papers/52353PubMed
55,853,147Coumarin anticoagulant drugs: hereditary resistance in man.Fed Proc1965https://conductscience.org/library/papers/5853147PubMed
66,047,959Dose response and minimal daily requirement for vitamin K in man.J Appl Physiol1967https://conductscience.org/library/papers/6047959PubMed
814,113,369THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.Thromb Diath Haemorrh1964https://conductscience.org/library/papers/14113369PubMed
10782,840Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.Drugs1976https://conductscience.org/library/papers/782840PubMed
114,723,259Dose-dependent enzyme induction.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723259PubMed
124,584,153Kinetics of warfarin absorption in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4584153PubMed
1313,804,621Metabolism of drugs in subjects with Laennec's cirrhosis.Med Exp Int J Exp Med1959https://conductscience.org/library/papers/13804621PubMed
144,830,225Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.J Clin Invest1974https://conductscience.org/library/papers/4830225PubMed
15871,666May mothers given warfarin breast-feed their infants?Br Med J1977https://conductscience.org/library/papers/871666PubMed
164,397,794Drug interactions with coumarin anticoagulants. 2.N Engl J Med1971https://conductscience.org/library/papers/4397794PubMed
175,124,275Vitamin K in hereditary resistance to oral anticoagulant drugs.Am J Physiol1971https://conductscience.org/library/papers/5124275PubMed
184,184,022Effect of heptabarbital on the response to bishydroxycoumarin in man.J Lab Clin Med1969https://conductscience.org/library/papers/4184022PubMed
194,969,847Vitamin K deficiency in adults.Nutr Rev1968https://conductscience.org/library/papers/4969847PubMed
2014,409,839Dangers of prolonged anticoagulant therapy in hepatic disease. Diathesis and intercurrent acute hepatitis.J Am Med Assoc1960https://conductscience.org/library/papers/14409839PubMed
215,765,021Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin.J Clin Invest1969https://conductscience.org/library/papers/5765021PubMed
2214,482,918Effect of sodium dextrothyroxine in patients receiving anticoagulants.N Engl J Med1962https://conductscience.org/library/papers/14482918PubMed

See all 35 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
21,972,237Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.J Pharmacol Exp Ther2012https://conductscience.org/library/papers/21972237PubMed
18,685,566Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.Clin Pharmacol Ther2008https://conductscience.org/library/papers/18685566PubMed
18,596,683Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.Clin Pharmacol Ther2008https://conductscience.org/library/papers/18596683PubMed
17,921,187Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/17921187PubMed
17,325,732Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans.Pharmacogenomics J2008https://conductscience.org/library/papers/17325732PubMed
8,824,029The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.Ir J Med Sci1996https://conductscience.org/library/papers/8824029PubMed
7,588,995Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits.Eur J Drug Metab Pharmacokinet1995https://conductscience.org/library/papers/7588995PubMed
6,802,293Therapeutic control of anticoagulant treatment.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6802293PubMed
3,567,026Attitudes to development of drug therapy in Scandinavia.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3567026PubMed
3,542,339Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.Clin Pharmacokinet1986https://conductscience.org/library/papers/3542339PubMed
3,435,692Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3435692PubMed
3,044,427Warfarin dosage requirements: prospective clinical trial of a method for prediction from the response to a single dose.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3044427PubMed
2,612,552A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2612552PubMed
369,763Clinical pharmacokinetics of oral anticoagulants.Clin Pharmacokinet1979https://conductscience.org/library/papers/369763PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/338281

GET https://conductscience.org/api/papers/v1/338281/references?page=2